Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRATA: Aranesp in Transplant-Related Anemia
NCT00117065Phase 4Completed
- Sponsor
- Amgen
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
Phase 4, open-label, single-arm trial of darbepoetin alfa in anemia, sponsored by Amgen. Primary endpoint: Hemoglobin values. Status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00117065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117065.